Alkermes (ALKS) Price to Sales (2010 - 2026)
Alkermes' (ALKS) quarterly Price to Sales came in at 17.7 in Q2 2026, up 46.42% year-over-year from 12.09 in Q2 2025, and up 18.15% quarter-over-quarter from 14.98 in Q1 2026.
Analysis
Alkermes (ALKS) Price to Sales (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Price to Sales for 17 consecutive years, with 17.7 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Sales rose 46.42% year-over-year to 17.7 in Q2 2026; TTM through Jun 2026 was 5.26, a 67.81% increase from a year earlier, with the FY2025 full-year figure at 3.14, up 4.85% from the prior year.
- Price to Sales was 17.7 for Q2 2026 at Alkermes, up from 14.98 in the prior quarter.
- Over five years, Price to Sales peaked at 17.76 in Q1 2025 and troughed at 8.44 in Q2 2023.
- A 5-year average of 13.56 and a median of 12.82 in 2024 frame the typical range for Price to Sales.
- Across the five-year window, Price to Sales plunged 52.34% in 2023 and soared 46.42% in 2026, its largest moves.
- Over 5 years, Price to Sales stood at 14.1 in 2022, then fell by 12.96% to 12.27 in 2023, then slipped by 11.6% to 10.85 in 2024, then rose by 11.08% to 12.05 in 2025, then soared by 46.89% to 17.7 in 2026.
- The last three Price to Sales figures came in at 17.7 (Q2 2026), 14.98 (Q1 2026), and 12.05 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.50 Bn | 624.74 Bn | 17.26 Bn |
| 2 | AbbVie | 443.58 Bn | 437.01 Bn | 12.70 Bn |
| 3 | Merck | 365.15 Bn | 358.01 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.63 Bn | 258.94 Bn | 11.24 Bn |
| 5 | Pfizer | 158.52 Bn | 146.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.37 Bn | 44.99 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.95 Bn | 43.95 Bn | - |
| 8 | Incyte | 25.37 Bn | 20.83 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn |
| 10 | Alkermes | 7.57 Bn | 6.92 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.70 |
| Mar 31, 2026 | 14.98 |
| Dec 31, 2025 | 12.05 |
| Sep 30, 2025 | 12.57 |
| Jun 30, 2025 | 12.09 |
| Mar 31, 2025 | 17.76 |
| Dec 31, 2024 | 10.85 |
| Sep 30, 2024 | 11.97 |
| Jun 30, 2024 | 10.02 |
| Mar 31, 2024 | 13.07 |
| Dec 31, 2023 | 12.27 |
| Sep 30, 2023 | 12.26 |
| Jun 30, 2023 | 8.44 |
| Mar 31, 2023 | 16.28 |
| Dec 31, 2022 | 14.10 |
| Sep 30, 2022 | 14.54 |
| Jun 30, 2022 | 17.71 |
| Mar 31, 2022 | 15.42 |
| Dec 31, 2021 | 11.61 |
| Sep 30, 2021 | 16.95 |